Skip to content
Screener

Upstream Bio, Inc. UPB Market capitalization

Market capitalization at other companies

Amgen logo
AmgenAMGN
$195.44B+31.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$65.37B+15.9%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$738.82M+349%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$662.83M+1,237%
Savara logo
SavaraSVRA
$1.26B+220%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.59B+180%

Other financials

Income statement

See full
Revenue$773.0K-17.5%
Operating income-$42.4M+4.5%
Net income-$39.7M+0.7%
EPS (diluted)-$0.73+1.4%

Balance sheet

See full
Cash & equivalents$79.4M+74.7%
Total debt$954.0K-38.9%
Total equity$271.0M-33.7%
Total assets$281.2M-33.1%

Cash flow

See full
Operating cash flow-$35.6M+9.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Enterprise value$316.1M-61.6%
P/S124.9×-195×

Profitability

See full
Operating margin-5,382.6%+1,393pp
Net margin-4,955.7%+2,041pp

Returns & leverage

See full
Return on equity-46%
Debt / equity0.0×
Current ratio28×-10.3×

Where this comes from

Computed from the period-end share price: $376.59M.

The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026. Open the filing →

Filed
Aug 11, 2026, 7:10 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-343417

FAQ

What is Upstream Bio, Inc.'s market capitalization?
Upstream Bio, Inc. (UPB) reported market capitalization of $376.59M in Q2 2026.
How has Upstream Bio, Inc.'s market capitalization changed year-over-year?
Upstream Bio, Inc.'s market capitalization decreased by 38.5% year-over-year, from $612.71M to $376.59M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about Upstream Bio, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude